pmc logo imageJournal ListSearchpmc logo image
Logo of neurorxJournal URL: redirect3.cgi?&&auth=0Z_YbZTae9vwxoYSb3CGentMPRVnEY_5U_mRdYAQp&reftype=publisher&article-id=1201316&issue-id=121201&journal-id=246&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://www.neurorx.org
NeuroRx. 2005 October; 2(4): 572–578.
PMCID: PMC1201316
The Quest for Market Exclusivity in Biotechnology: Navigating the Patent Minefield
Judge David M. Gersten
Third District Court of Appeal, Miami, Florida 33175
Address correspondence and reprint requests to Judge David M. Gersten, Third District Court of Appeal, 2001 SW 117 Avenue, Miami, FL 33175. E-mail: gerstend/at/flcourts.org
Abstract
Summary: A patent is a legal device that grants an inventor market exclusivity over a new invention or medication. Market exclusivity can mean tremendous economic rewards for the patent holder because it provides the inventor with a monopoly over the invention for the 20-year patent term. Obtaining a patent and retaining market exclusivity can be a treacherous process, especially in the arena of biotechnology patents. Scientific, legal, and practical considerations must be carefully weighed to best protect an inventor's rights. This article explores some common patenting pitfalls as well as emerging issues that are specific to the area of biotechnology patenting.
Keywords: Patent, market exclusivity, litigation, intellectual property